NeoplasmsAntineoplastic AgentsRadiation DosageRadiation, IonizingCell Line, TumorRadiation InjuriesDose-Response Relationship, RadiationRadiation ToleranceDrug Screening Assays, AntitumorApoptosisDrug Resistance, NeoplasmRadiationMice, NudeCell SurvivalBreast NeoplasmsRadiation ProtectionXenograft Model Antitumor AssaysDrug Delivery SystemsRadiation MonitoringAntineoplastic Agents, PhytogenicDoxorubicinCisplatinCell ProliferationGene Expression Regulation, NeoplasticTumor Cells, CulturedColonic NeoplasmsLung NeoplasmsAntibiotics, AntineoplasticProstatic NeoplasmsEarly Detection of CancerCombined Modality TherapyRadiation OncologyOvarian NeoplasmsMolecular Targeted TherapyRadiotherapyDNA DamageDrug CarriersNeoplasm ProteinsCell CycleNeoplasm TransplantationTumor Suppressor Protein p53Dose-Response Relationship, DrugNeoplasm MetastasisNeoplasms, Radiation-InducedPaclitaxelGamma RaysAntineoplastic Combined Chemotherapy ProtocolsRadiation-Sensitizing AgentsSignal TransductionPancreatic NeoplasmsClinical Trials as TopicRNA, Small InterferingStomach NeoplasmsTime FactorsDrug SynergismBlotting, WesternNanoparticlesModels, BiologicalCosmic RadiationNeoplasm InvasivenessDrug DesignCamptothecinRadiotherapy DosageFluorouracilTransplantation, HeterologousCarcinoma, Squamous CellEnzyme InhibitorsTreatment OutcomeRadiation Injuries, ExperimentalNanomedicineInhibitory Concentration 50Reverse Transcriptase Polymerase Chain ReactionMutationEtoposideCell DivisionRadiation PneumonitisCancer VaccinesTumor BurdenRNA, MessengerNeoplasms, ExperimentalRadiometrySurvival AnalysisDrug Resistance, MultiplePrognosisCarcinomaNeovascularization, PathologicCarcinoma, Non-Small-Cell LungAdenocarcinomaFlow CytometryNational Cancer Institute (U.S.)Mice, Inbred BALB CDNA RepairAntimetabolites, AntineoplasticAntibodies, MonoclonalSensitivity and SpecificityRetrospective StudiesTumor Markers, BiologicalSurvival RateHCT116 CellsUterine Cervical Neoplasms